Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001641172-25-023211
Filing Date
2025-08-12
Accepted
2025-08-12 16:30:49
Documents
48
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q form10-q.htm   iXBRL 10-Q 747000
2 EX-31.1 ex31-1.htm EX-31.1 15498
3 EX-31.2 ex31-2.htm EX-31.2 15595
4 EX-32.1 ex32-1.htm EX-32.1 8274
  Complete submission text file 0001641172-25-023211.txt   4046054

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE brtx-20250630.xsd EX-101.SCH 26268
6 XBRL CALCULATION FILE brtx-20250630_cal.xml EX-101.CAL 40631
7 XBRL DEFINITION FILE brtx-20250630_def.xml EX-101.DEF 135399
8 XBRL LABEL FILE brtx-20250630_lab.xml EX-101.LAB 261183
9 XBRL PRESENTATION FILE brtx-20250630_pre.xml EX-101.PRE 217771
50 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 580405
Mailing Address 40 MARCUS DRIVE MELVILLE NY 11747
Business Address 40 MARCUS DRIVE MELVILLE NY 11747 (631) 760-8100
BioRestorative Therapies, Inc. (Filer) CIK: 0001505497 (see all company filings)

EIN.: 301341024 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37603 | Film No.: 251207234
SIC: 8090 Services-Misc Health & Allied Services, NEC
(CF Office: 08 Industrial Applications and Services)